DCF — MOUNT CARMEL HEALTH
Enterprise Value: $-1.3B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.3B
Enterprise Value
$-416.1M
PV of Cash Flows
$-906.5M
PV of Terminal Value
$-1.5B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $757.9M | $-83.7M | -11.0% | $-115.7M | $-105.2M |
| Year 2 | $780.6M | $-78.4M | -10.0% | $-111.4M | $-92.1M |
| Year 3 | $804.0M | $-72.7M | -9.0% | $-106.7M | $-80.2M |
| Year 4 | $828.1M | $-70.7M | -9.0% | $-105.8M | $-72.2M |
| Year 5 | $853.0M | $-70.7M | -8.0% | $-106.8M | $-66.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.3B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$735.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1153996920893068
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5